Ethics body approves another clinical trial using MGC Pharma’s epilepsy drug

STOCKHEAD MGC (ASX:MXC) will conduct a head-to-head clinical study on severe intractable epilepsy in collaboration with Cannabis Access Clinics and Epilepsy Action Australia, a direct comparison assessing the efficacy of low-THC…

Continue ReadingEthics body approves another clinical trial using MGC Pharma’s epilepsy drug